Pharmacotherapy alleviates pathological changes in human direct reprogrammed neuronal cell model of myotonic dystrophy type 1

Myotonic dystrophy type 1 (DM1) is a trinucleotide repeat disorder affecting multiple organs. However, most of the research is focused on studying and treating its muscular symptoms. On the other hand, despite the significant impact of the neurological symptoms on patients’ quality of life, no drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Eltahir, Mougina K., Nakamori, Masayuki, Hattori, Satoshi, Kimura, Takashi, Mochizuki, Hideki, Nagano, Seiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249217/
https://www.ncbi.nlm.nih.gov/pubmed/35776705
http://dx.doi.org/10.1371/journal.pone.0269683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249217/
https://www.ncbi.nlm.nih.gov/pubmed/35776705
http://dx.doi.org/10.1371/journal.pone.0269683

Ejemplares similares